Glycolytic flux sustains human Th1 identity and effector function via STAT1 glycosylation
Ariful Haque Abir(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dirk Mielenz(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dimitrios Mougiakakos(Otto-von-Guericke-Universität Magdeburg), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Heiko Bruns(Friedrich-Alexander-Universität Erlangen-Nürnberg), Benjamin Frey(Friedrich-Alexander-Universität Erlangen-Nürnberg), Udo S. Gaipl(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 0
Related Papers
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
|Science Immunology|2022|280
The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts
|Immunity|2021|245
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy
|Cell|2024|227
Advancements and challenges in CAR T cell therapy in autoimmune diseases
|Nature Reviews Rheumatology|2024|203